skip to main content

Ankylosing Spondylitis

Diagnosis and management of axial spondyloarthritis.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Rheumatology
Turn this into CPDPractise this topic, identify learning gaps and prepare a CPD draft you can review.

Clinical Guidelines

2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis
National
BSR and BHPR guideline for the treatment of axial spondyloarthritis
National
CKS: Axial spondyloarthritis (including ankylosing spondylitis)
National
NICE guideline [NG100]
National
NICE guideline [NG65]: Spondyloarthritis
National
NICE technology appraisal guidance [TA383]: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
National
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Local
ASAS-EULAR recommendations for the management of axial spondyloarthritis, including ankylosing spondylitis and non-radiographic axial spondyloarthritis: 2022 update
Local
First update of the international ASAS consensus statement for the use of anti‐TNF agents in patients with ankylosing spondylitis
Local